196 related articles for article (PubMed ID: 16199656)
1. ACOG committee opinion. Number 318, October 2005. Screening for Tay-Sachs disease.
ACOG Committee on Genetics
Obstet Gynecol; 2005 Oct; 106(4):893-4. PubMed ID: 16199656
[TBL] [Abstract][Full Text] [Related]
2. The frequency of Tay-Sachs disease causing mutations in the Brazilian Jewish population justifies a carrier screening program.
Rozenberg R; Pereira Lda V
Sao Paulo Med J; 2001 Jul; 119(4):146-9. PubMed ID: 11500789
[TBL] [Abstract][Full Text] [Related]
3. Tay-Sachs disease screening and counseling families at risk for metabolic disease.
Sutton VR
Obstet Gynecol Clin North Am; 2002 Jun; 29(2):287-96. PubMed ID: 12108829
[TBL] [Abstract][Full Text] [Related]
4. Carrier screening for cystic fibrosis, Gaucher disease, and Tay-Sachs disease in the Ashkenazi Jewish population: the first 1000 cases at New York University Medical Center, New York, NY.
Kronn D; Jansen V; Ostrer H
Arch Intern Med; 1998 Apr; 158(7):777-81. PubMed ID: 9554684
[TBL] [Abstract][Full Text] [Related]
5. The incidence and carrier frequency of Tay-Sachs disease in the French-Canadian population of Quebec based on retrospective data from 24 years, 1992-2015.
Sillon G; Allard P; Drury S; Rivière JB; De Bie I
J Genet Couns; 2020 Dec; 29(6):1173-1185. PubMed ID: 32302469
[TBL] [Abstract][Full Text] [Related]
6. Heterozygote screening for Tay-Sachs disease: past successes and future challenges.
Natowicz MR; Prence EM
Curr Opin Pediatr; 1996 Dec; 8(6):625-9. PubMed ID: 9018448
[TBL] [Abstract][Full Text] [Related]
7. Tay-Sachs disease--carrier screening, prenatal diagnosis, and the molecular era. An international perspective, 1970 to 1993. The International TSD Data Collection Network.
Kaback M; Lim-Steele J; Dabholkar D; Brown D; Levy N; Zeiger K
JAMA; 1993 Nov; 270(19):2307-15. PubMed ID: 8230592
[TBL] [Abstract][Full Text] [Related]
8. Ethical Issues with Genetic Testing for Tay-Sachs.
Clayton T
J Christ Nurs; 2017; 34(4):246-249. PubMed ID: 28902054
[TBL] [Abstract][Full Text] [Related]
9. Tay Sachs disease in Australia: reduced disease incidence despite stable carrier frequency in Australian Jews.
Lew RM; Proos AL; Burnett L; Delatycki M; Bankier A; Fietz MJ
Med J Aust; 2012 Dec; 197(11):652-4. PubMed ID: 23230938
[TBL] [Abstract][Full Text] [Related]
10. Screening for genetic disorders among Jews: how should the Tay-Sachs screening program be continued?
Zlotogora J; Leventhal A
Isr Med Assoc J; 2000 Sep; 2(9):665-7. PubMed ID: 11062764
[TBL] [Abstract][Full Text] [Related]
11. Prenatal genetic carrier testing using triple disease screening.
Eng CM; Schechter C; Robinowitz J; Fulop G; Burgert T; Levy B; Zinberg R; Desnick RJ
JAMA; 1997 Oct; 278(15):1268-72. PubMed ID: 9333269
[TBL] [Abstract][Full Text] [Related]
12. Rapid nonradioactive tracer method for detecting carriers of the major Ashkenazi Jewish Tay-Sachs disease mutations.
Strasberg PM; Clarke JT
Clin Chem; 1992 Nov; 38(11):2249-55. PubMed ID: 1424119
[TBL] [Abstract][Full Text] [Related]
13. Tay-Sachs disease carrier screening: a 21-year experience.
D'Souza G; McCann CL; Hedrick J; Fairley C; Nagel HL; Kushner JD; Kessel R
Genet Test; 2000; 4(3):257-63. PubMed ID: 11142756
[TBL] [Abstract][Full Text] [Related]
14. Ashkenazi Jewish population screening for Tay-Sachs disease: the international and Australian experience.
Lew RM; Burnett L; Proos AL; Barlow-Stewart K; Delatycki MB; Bankier A; Aizenberg H; Field MJ; Berman Y; Fleischer R; Fietz M
J Paediatr Child Health; 2015 Mar; 51(3):271-9. PubMed ID: 24923490
[TBL] [Abstract][Full Text] [Related]
15. ACOG committee opinion. Number 298, August 2004. Prenatal and preconceptional carrier screening for genetic diseases in individuals of Eastern European Jewish descent.
ACOG Committee on Genetics
Obstet Gynecol; 2004 Aug; 104(2):425-8. PubMed ID: 15292027
[TBL] [Abstract][Full Text] [Related]
16. Screening for carriers of Tay-Sachs disease in the ultraorthodox Ashkenazi Jewish community in Israel.
Broide E; Zeigler M; Eckstein J; Bach G
Am J Med Genet; 1993 Aug; 47(2):213-5. PubMed ID: 8213907
[TBL] [Abstract][Full Text] [Related]
17. Prenatal Diagnosis of Tay-Sachs Disease.
Zhang J; Chen H; Kornreich R; Yu C
Methods Mol Biol; 2019; 1885():233-250. PubMed ID: 30506202
[TBL] [Abstract][Full Text] [Related]
18. Tay-Sachs disease carrier screening: a model for prevention of genetic disease.
Kaplan F
Genet Test; 1998; 2(4):271-92. PubMed ID: 10464605
[TBL] [Abstract][Full Text] [Related]
19. Determinants of utilization of Tay-Sachs screening.
Garber AP; Platt LD; Wang SJ; Jam K; Carlson DE; Rotter JI
Obstet Gynecol; 1993 Sep; 82(3):460-3. PubMed ID: 8355954
[TBL] [Abstract][Full Text] [Related]
20. Heterozygosity for Tay-Sachs and Sandhoff diseases in non-Jewish Americans with ancestry from Ireland, Great Britain, or Italy.
Branda KJ; Tomczak J; Natowicz MR
Genet Test; 2004; 8(2):174-80. PubMed ID: 15345116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
